Do analysts rate VSEE or DHAC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score VSee Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Digital Health Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has stronger valuation & earnings, VSEE or DHAC?

Digital Health Acquisition has lower revenue, but higher earnings than VSee Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio VSee Health $14.46M 0.02 -$14.71M -$0.54 N/A Digital Health Acquisition N/A N/A N/A N/A N/A

Do analysts recommend VSEE or UPHL?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score VSee Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 UpHealth 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Is VSEE or UPHL more profitable?

UpHealth has a net margin of 0.00% compared to VSee Health's net margin of -92.36%. UpHealth's return on equity of 0.00% beat VSee Health's return on equity. Company Net Margins Return on Equity Return on Assets VSee Health -92.36% -11,636.34% -68.62% UpHealth N/A N/A N/A

Do analysts recommend VSEE or BTTX?

Given Better Therapeutics' higher possible upside, analysts clearly believe Better Therapeutics is more favorable than VSee Health. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score VSee Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Better Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Do analysts recommend VSEE or BACK?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score VSee Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 IMAC 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has better valuation and earnings, VSEE or BACK?

IMAC has lower revenue, but higher earnings than VSee Health. VSee Health is trading at a lower price-to-earnings ratio than IMAC, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio VSee Health $14.46M 0.02 -$14.71M -$0.54 N/A IMAC $72.05K 0.01 -$9.42M -$3.12 N/A

Is VSEE or BACK more profitable?

IMAC has a net margin of 0.00% compared to VSee Health's net margin of -92.36%. IMAC's return on equity of 0.00% beat VSee Health's return on equity. Company Net Margins Return on Equity Return on Assets VSee Health -92.36% -11,636.34% -68.62% IMAC N/A N/A -325.44%

Does the media prefer VSEE or BACK?

In the previous week, VSee Health and VSee Health both had 2 articles in the media. VSee Health's average media sentiment score of 0.98 beat IMAC's score of 0.76 indicating that VSee Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment VSee Health 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive IMAC 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend ACONW or VSEE?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aclarion 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 VSee Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher earnings and valuation, ACONW or VSEE?

Aclarion has higher earnings, but lower revenue than VSee Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Aclarion $77.88K N/A N/A N/A N/A VSee Health $14.46M 0.02 -$14.71M -$0.54 N/A

Is ACONW or VSEE more profitable?

Aclarion has a net margin of 0.00% compared to VSee Health's net margin of -92.36%. Aclarion's return on equity of 0.00% beat VSee Health's return on equity. Company Net Margins Return on Equity Return on Assets Aclarion N/A N/A N/A VSee Health -92.36% -11,636.34% -68.62%

VSee Health (VSEE) Competitors

$0.08 0.00 (-3.07%)

Closing price 07/24/2026 04:00 PM Eastern

Extended Trading

$0.08 +0.00 (+1.01%)

As of 07/24/2026 07:34 PM Eastern

Compare

VSEE vs. DHAC, UPHL, BTTX, BACK, and ACONW

Should you buy VSee Health stock or one of its competitors? MarketBeat compares VSee Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with VSee Health include Digital Health Acquisition (DHAC), UpHealth (UPHL), Better Therapeutics (BTTX), IMAC (BACK), and Aclarion (ACONW). These companies are all part of the "healthcare" industry.

How does VSee Health compare to Digital Health Acquisition?

VSee Health (NASDAQ:VSEE) and Digital Health Acquisition (NASDAQ:DHAC) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, media sentiment, institutional ownership, earnings, profitability and dividends.

In the previous week, VSee Health had 2 more articles in the media than Digital Health Acquisition. MarketBeat recorded 2 mentions for VSee Health and 0 mentions for Digital Health Acquisition. VSee Health's average media sentiment score of 0.98 beat Digital Health Acquisition's score of 0.00 indicating that VSee Health is being referred to more favorably in the media.

Company	Overall Sentiment
VSee Health	Positive
Digital Health Acquisition	Neutral

Digital Health Acquisition has a net margin of 0.00% compared to VSee Health's net margin of -92.36%. Digital Health Acquisition's return on equity of 0.00% beat VSee Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
VSee Health	-92.36%	-11,636.34%	-68.62%
Digital Health Acquisition	N/A	N/A	N/A

Digital Health Acquisition has lower revenue, but higher earnings than VSee Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
VSee Health	$14.46M	0.02	-$14.71M	-$0.54	N/A
Digital Health Acquisition	N/A	N/A	N/A	N/A	N/A

1.0% of VSee Health shares are held by institutional investors. Comparatively, 1.0% of Digital Health Acquisition shares are held by institutional investors. 19.7% of VSee Health shares are held by insiders. Comparatively, 6.6% of Digital Health Acquisition shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
VSee Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Digital Health Acquisition	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

VSee Health beats Digital Health Acquisition on 5 of the 8 factors compared between the two stocks.

How does VSee Health compare to UpHealth?

VSee Health (NASDAQ:VSEE) and UpHealth (NYSE:UPHL) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, profitability, risk, valuation, earnings, analyst recommendations and media sentiment.

VSee Health has higher earnings, but lower revenue than UpHealth. VSee Health is trading at a lower price-to-earnings ratio than UpHealth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
VSee Health	$14.46M	0.02	-$14.71M	-$0.54	N/A
UpHealth	$130M	0.00	-$56.42M	$1.98	0.00

In the previous week, VSee Health had 2 more articles in the media than UpHealth. MarketBeat recorded 2 mentions for VSee Health and 0 mentions for UpHealth. VSee Health's average media sentiment score of 0.98 beat UpHealth's score of 0.00 indicating that VSee Health is being referred to more favorably in the media.

Company	Overall Sentiment
VSee Health	Positive
UpHealth	Neutral

UpHealth has a net margin of 0.00% compared to VSee Health's net margin of -92.36%. UpHealth's return on equity of 0.00% beat VSee Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
VSee Health	-92.36%	-11,636.34%	-68.62%
UpHealth	N/A	N/A	N/A

1.0% of VSee Health shares are owned by institutional investors. Comparatively, 56.1% of UpHealth shares are owned by institutional investors. 19.7% of VSee Health shares are owned by insiders. Comparatively, 34.2% of UpHealth shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
VSee Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
UpHealth	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

UpHealth beats VSee Health on 8 of the 13 factors compared between the two stocks.

How does VSee Health compare to Better Therapeutics?

VSee Health (NASDAQ:VSEE) and Better Therapeutics (NASDAQ:BTTX) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, media sentiment, institutional ownership, risk, profitability, analyst recommendations and dividends.

1.0% of VSee Health shares are owned by institutional investors. Comparatively, 34.0% of Better Therapeutics shares are owned by institutional investors. 19.7% of VSee Health shares are owned by insiders. Comparatively, 51.4% of Better Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, VSee Health had 2 more articles in the media than Better Therapeutics. MarketBeat recorded 2 mentions for VSee Health and 0 mentions for Better Therapeutics. VSee Health's average media sentiment score of 0.98 beat Better Therapeutics' score of 0.00 indicating that VSee Health is being referred to more favorably in the media.

Company	Overall Sentiment
VSee Health	Positive
Better Therapeutics	Neutral

Given Better Therapeutics' higher possible upside, analysts clearly believe Better Therapeutics is more favorable than VSee Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
VSee Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Better Therapeutics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

VSee Health has higher revenue and earnings than Better Therapeutics. VSee Health is trading at a lower price-to-earnings ratio than Better Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
VSee Health	$14.46M	0.02	-$14.71M	-$0.54	N/A
Better Therapeutics	N/A	N/A	-$39.76M	-$0.39	N/A

Better Therapeutics has a net margin of 0.00% compared to VSee Health's net margin of -92.36%. Better Therapeutics' return on equity of 0.00% beat VSee Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
VSee Health	-92.36%	-11,636.34%	-68.62%
Better Therapeutics	N/A	N/A	N/A

Summary

Better Therapeutics beats VSee Health on 8 of the 13 factors compared between the two stocks.

How does VSee Health compare to IMAC?

VSee Health (NASDAQ:VSEE) and IMAC (NASDAQ:BACK) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, media sentiment, institutional ownership, profitability, analyst recommendations, valuation and dividends.

IMAC has lower revenue, but higher earnings than VSee Health. VSee Health is trading at a lower price-to-earnings ratio than IMAC, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
VSee Health	$14.46M	0.02	-$14.71M	-$0.54	N/A
IMAC	$72.05K	0.01	-$9.42M	-$3.12	N/A

In the previous week, VSee Health and VSee Health both had 2 articles in the media. VSee Health's average media sentiment score of 0.98 beat IMAC's score of 0.76 indicating that VSee Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
VSee Health	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
IMAC	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
VSee Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
IMAC	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

IMAC has a net margin of 0.00% compared to VSee Health's net margin of -92.36%. IMAC's return on equity of 0.00% beat VSee Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
VSee Health	-92.36%	-11,636.34%	-68.62%
IMAC	N/A	N/A	-325.44%

1.0% of VSee Health shares are owned by institutional investors. Comparatively, 5.8% of IMAC shares are owned by institutional investors. 19.7% of VSee Health shares are owned by company insiders. Comparatively, 12.3% of IMAC shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

VSee Health beats IMAC on 7 of the 12 factors compared between the two stocks.

How does VSee Health compare to Aclarion?

Aclarion (NASDAQ:ACONW) and VSee Health (NASDAQ:VSEE) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, risk, profitability, analyst recommendations, valuation, earnings and dividends.

Aclarion has higher earnings, but lower revenue than VSee Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aclarion	$77.88K	N/A	N/A	N/A	N/A
VSee Health	$14.46M	0.02	-$14.71M	-$0.54	N/A

1.0% of VSee Health shares are owned by institutional investors. 19.7% of VSee Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Aclarion and Aclarion both had 2 articles in the media. Aclarion's average media sentiment score of 1.44 beat VSee Health's score of 0.98 indicating that Aclarion is being referred to more favorably in the media.

Company	Overall Sentiment
Aclarion	Positive
VSee Health	Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aclarion	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
VSee Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Aclarion has a net margin of 0.00% compared to VSee Health's net margin of -92.36%. Aclarion's return on equity of 0.00% beat VSee Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aclarion	N/A	N/A	N/A
VSee Health	-92.36%	-11,636.34%	-68.62%

Summary

Aclarion and VSee Health tied by winning 4 of the 8 factors compared between the two stocks.

Get VSee Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VSEE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

VSEE vs. The Competition

Export

Metric	VSee Health	INTERNET SOFTWARE Industry	Computer Sector	NASDAQ Exchange
Market Cap	$293K	$16.81B	$37.24B	$12.28B
Dividend Yield	N/A	1.78%	3.17%	9.79%
P/E Ratio	-0.15	63.44	76.70	23.71
Price / Sales	0.02	34.08	590.91	75.28
Price / Cash	N/A	75.16	44.48	59.64
Price / Book	-7.90	6.29	9.07	6.07
Net Income	-$14.71M	$385.08M	$1.07B	$331.99M
7 Day Performance	N/A	-5.37%	-1.81%	-0.63%
1 Month Performance	N/A	0.91%	-2.70%	-2.00%
1 Year Performance	N/A	-19.86%	133.84%	13.62%

VSee Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
VSEE VSee Health	0.333 of 5 stars	$0.08 -3.1%	N/A	-94.2%	$293K	$14.46M	N/A	N/A	High Trading Volume
DHAC Digital Health Acquisition	N/A	$0.09 -5.2%	N/A	-94.2%	$332K	N/A	N/A	2,021	High Trading Volume
UPHL UpHealth	N/A	$0.00 +200.0%	N/A	+50.0%	$6K	$130M	N/A	1,750	Gap Up
BTTX Better Therapeutics	N/A	N/A	N/A	N/A	$4K	N/A	N/A	40
BACK IMAC	N/A	$0.00 -98.8%	N/A	-99.7%	$1K	$72.05K	N/A	180	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:VSEE) was last updated on 7/25/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

VSee Health (VSEE) Competitors

VSEE vs. DHAC, UPHL, BTTX, BACK, and ACONW

How does VSee Health compare to Digital Health Acquisition?

Summary

How does VSee Health compare to UpHealth?

Summary

How does VSee Health compare to Better Therapeutics?

Summary

How does VSee Health compare to IMAC?

Summary

How does VSee Health compare to Aclarion?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

VSEE vs. The Competition

VSee Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

VSee Health (VSEE) Competitors

VSEE vs. DHAC, UPHL, BTTX, BACK, and ACONW

How does VSee Health compare to Digital Health Acquisition?

Does the media refer more to VSEE or DHAC?

Is VSEE or DHAC more profitable?

Which has stronger valuation & earnings, VSEE or DHAC?

Do institutionals & insiders hold more shares of VSEE or DHAC?

Do analysts rate VSEE or DHAC?

Summary

How does VSee Health compare to UpHealth?

Which has higher valuation and earnings, VSEE or UPHL?

Does the media prefer VSEE or UPHL?

Is VSEE or UPHL more profitable?

Do institutionals & insiders believe in VSEE or UPHL?

Do analysts recommend VSEE or UPHL?

Summary

How does VSee Health compare to Better Therapeutics?

Do insiders & institutionals believe in VSEE or BTTX?

Does the media favor VSEE or BTTX?

Do analysts recommend VSEE or BTTX?

Which has higher valuation & earnings, VSEE or BTTX?

Is VSEE or BTTX more profitable?

Summary

How does VSee Health compare to IMAC?

Which has better valuation and earnings, VSEE or BACK?

Does the media prefer VSEE or BACK?

Do analysts recommend VSEE or BACK?

Is VSEE or BACK more profitable?

Do insiders & institutionals believe in VSEE or BACK?

Summary

How does VSee Health compare to Aclarion?

Which has higher earnings and valuation, ACONW or VSEE?

Do insiders & institutionals have more ownership in ACONW or VSEE?

Does the media refer more to ACONW or VSEE?

Do analysts recommend ACONW or VSEE?

Is ACONW or VSEE more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

VSEE vs. The Competition

VSee Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools